Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 11881-11890 Newer>

The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: General Dynamics Musters Last year was good to defense contractor General Dynamics, the shares of which bucked the market's overall stagnant trend to rise as much as 20% toward year's end. Will 2006 be similarly kind?
The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: Silicon Labs Gels The semiconductor company is up 47% over the past 52 weeks. Can its winning streak continue?
The Motley Fool January 24, 2006 Mike Cianciolo	E*Trade's Compound Growth The online brokerage puts customer cash to good use. Even though the stock has doubled over the past year, it still looks reasonably valued.
The Motley Fool January 24, 2006 Stephen D. Simpson	Shake a Leg, J&J! J&J isn't a perfect story, but investors who buy today and hold for a while will be happy they did.
The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: Qualcomm Calling High quality rarely comes without a high price tag. If you want to own a piece of Qualcomm, it's going to cost you 37 times earnings (and the same multiple to free cash flow) to do it.
The Motley Fool January 24, 2006 John Reeves	Johnson & Johnson Robust in 2005: Fool by Numbers Johnson & Johnson released fiscal year 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights...
The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: Hershey Unwraps Focus on the margins -- there investors will find the proof of how well Hershey is managing to offset its raw materials costs.
The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: Is Acxiom Just Spinning? Buying Acxiom looks like a better idea than betting against it. The company's trailing-12-month P/E of 42 may not look cheap, but its mammoth cash flows give the firm an ultra-cheap price-to-free-cash-flow ratio of 8.
The Motley Fool January 24, 2006 Stephen D. Simpson	Reddy, Set, Go! After a tough stretch, leading Indian pharmaceutical company Dr. Reddy's may be ready to move again. This is still a turnaround story, though, so investors unable or unwilling to assume above-average risk should probably steer clear.
The Motley Fool January 24, 2006 Rich Smith	Foolish Forecast: Colgate-Palmolive in the Wash Will the stock's winning streak continue? Wednesday's fourth-quarter and full-year 2005 results could factor heavily in answering that question.
<Older 11881-11890 Newer> Return to current articles.